Zydus Launches Season 3 of ‘Easiest Exam’ Breast Cancer Campaign Kumar Jeetendra | October 17, 2026 Marking Breast Cancer Awareness Month, Zydus has launched Season 3 of its nationwide ‘Easiest Exam’ campaign, encouraging women to spend just three minutes every month checking their breasts for unusual changes. Breast cancer continues to be a growing health concern in India. A recent study found that the country’s breast cancer incidence rate increased from …
Mankind Pharma Enters CAR-T Therapy with Armed Cell Acquisition Kumar Jeetendra | October 17, 2026 As a part of its long term strategy to build a global innovation-led pharmaceutical business, Mankind Pharma (BSE: 543904 | NSE: MANKIND) through its subsidiary Mankind Pharma (Netherlands) B.V., has entered into a definitive agreement under which Mankind Pharma will acquire a majority stake in Armed Cell Therapeutics B.V., a Belgium-incorporated biotechnology company developing next-generation …
Zydus, MSN Launch First Generic Adempas® in the U.S. Kumar Jeetendra | October 17, 2026 Zydus Lifesciences Limited (Zydus), in partnership with MSN Laboratories Private Limited (MSN), today announced the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg and 2.5 mg, in the United States. Zydus and MSN are the first companies to launch a generic version of Adempas® (riociguat) in the U.S. market. The product …
